M
Melissa Duarte
Researcher at Harvard University
Publications - 15
Citations - 1967
Melissa Duarte is an academic researcher from Harvard University. The author has contributed to research in topics: Triple-negative breast cancer & Targeted therapy. The author has an hindex of 8, co-authored 14 publications receiving 1653 citations. Previous affiliations of Melissa Duarte include Brigham and Women's Hospital.
Papers
More filters
Journal ArticleDOI
Evidence for Network Evolution in an Arabidopsis Interactome Map
Matija Dreze,Anne-Ruxandra Carvunis,Benoit Charloteaux,Mary Galli,Samuel J. Pevzner,Murat Tasan,Yong-Yeol Ahn,Padmavathi Balumuri,Albert-László Barabási,Vanessa Bautista,Pascal Braun,Danielle Byrdsong,Huaming Chen,Jonathan D. Chesnut,Michael E. Cusick,Jeffery L. Dangl,Chris de los Reyes,Amélie Dricot,Melissa Duarte,Joseph R. Ecker,Changyu Fan,Lantian Gai,Fana Gebreab,Gourab Ghoshal,Patrick Gilles,Bryan J. Gutierrez,Tong Hao,David E. Hill,Christopher Kim,Rosa Cheuk Kim,Claire Lurin,Andrew MacWilliams,Uday Matrubutham,Tijana Milenkovic,Jyotika Mirchandani,Dario Monachello,Jonathan D. Moore,M. Shahid Mukhtar,Eric Olivares,Suswapna Patnaik,Matthew M. Poulin,Natasa Przulj,Rosa Quan,Sabrina Rabello,Gopalakrishna Ramaswamy,Patrick Reichert,Edward A. Rietman,Thomas Rolland,Viviana Romero,Frederick P. Roth,Balaji Santhanam,Robert J. Schmitz,Paul Shinn,William Spooner,Joshua C. Stein,Geetha M. Swamilingiah,Stanley Tam,Jean Vandenhaute,Marc Vidal,Selma Waaijers,Doreen Ware,Evan M. Weiner,Stacy Wu,Junshi Yazaki +63 more
TL;DR: A proteome-wide binary protein-protein interaction map for the interactome network of the plant Arabidopsis thaliana containing about 6200 highly reliable interactions between about 2700 proteins is described.
Journal ArticleDOI
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer
Shaokun Shu,Charles Y. Lin,Housheng Hansen He,Robert M. Witwicki,Doris P. Tabassum,Justin M. Roberts,Michalina Janiszewska,Sung Jin Huh,Yi Liang,Jeremy Ryan,Ernest Doherty,Hisham Mohammed,Hao Guo,Daniel G. Stover,Muhammad B. Ekram,Guillermo Peluffo,Jonathan D. Brown,Clive D'Santos,Ian E. Krop,Deborah A. Dillon,Michael R. McKeown,Christopher J. Ott,Jun Qi,Min Ni,Prakash Rao,Melissa Duarte,Shwu Yuan Wu,Cheng Ming Chiang,Lars Anders,Richard A. Young,Eric P. Winer,Antony Letai,William T. Barry,Jason S. Carroll,Henry W. Long,Myles Brown,X. Shirley Liu,X. Shirley Liu,Clifford A. Meyer,James E. Bradner,James E. Bradner,Kornelia Polyak,Kornelia Polyak +42 more
TL;DR: In this article, the preferential sensitivity of triple negative breast cancer (TNBC) cells to BET bromodomain inhibition in vitro and in vivo has been investigated and a rationale for clinical investigation and further motivation to understand mechanisms of resistance.
Journal ArticleDOI
Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins
Orit Rozenblatt-Rosen,Rahul C. Deo,Rahul C. Deo,Megha Padi,Guillaume Adelmant,Michael A. Calderwood,Thomas Rolland,Miranda Grace,Miranda Grace,Amélie Dricot,Manor Askenazi,Maria Tavares,Sam Pevzner,Sam Pevzner,Fieda Abderazzaq,Danielle Byrdsong,Anne-Ruxandra Carvunis,Alyce A. Chen,Alyce A. Chen,Jingwei Cheng,Jingwei Cheng,Mick Correll,Melissa Duarte,Melissa Duarte,Changyu Fan,Mariet C.W. Feltkamp,Scott B. Ficarro,Rachel Franchi,Rachel Franchi,Brijesh K. Garg,Natali Gulbahce,Tong Hao,Amy M. Holthaus,Amy M. Holthaus,Robert James,Anna Korkhin,Anna Korkhin,Larisa Litovchick,Larisa Litovchick,Jessica C. Mar,Theodore R. Pak,Sabrina Rabello,Renee Rubio,Yun Shen,Saurav Singh,Jennifer M. Spangle,Jennifer M. Spangle,Murat Tasan,Murat Tasan,Shelly Wanamaker,Shelly Wanamaker,James T. Webber,Jennifer Roecklein-Canfield,Jennifer Roecklein-Canfield,Eric Johannsen,Eric Johannsen,Albert-László Barabási,Rameen Beroukhim,Rameen Beroukhim,Rameen Beroukhim,Elliott Kieff,Elliott Kieff,Michael E. Cusick,David E. Hill,Karl Münger,Karl Münger,Jarrod A. Marto,John Quackenbush,Frederick P. Roth,James A. DeCaprio,James A. DeCaprio,Marc Vidal +71 more
TL;DR: It is shown that systematic analyses of host targets of viral proteins can identify cancer genes with a success rate on a par with their identification through functional genomics and large-scale cataloguing of tumour mutations, to increase the specificity of cancer gene identification.
Journal ArticleDOI
Oncogenic Deregulation of EZH2 as an Opportunity for Targeted Therapy in Lung Cancer
Haikuo Zhang,Jun Qi,Jaime M. Reyes,Lewyn Li,Prakash Rao,Fugen Li,Charles Y. Lin,Jennifer A. Perry,Matthew A. Lawlor,Alexander J. Federation,Thomas De Raedt,Yvonne Y. Li,Yan Liu,Melissa Duarte,Yanxi Zhang,Grit S. Herter-Sprie,Eiki Kikuchi,Julian Carretero,Charles M. Perou,Jacob B. Reibel,Joshiawa Paulk,Roderick T. Bronson,Hideo Watanabe,Christine Fillmore Brainson,Carla F. Kim,Peter S. Hammerman,Myles Brown,Karen Cichowski,Henry W. Long,James E. Bradner,Kwok-Kin Wong +30 more
TL;DR: The causal role of EZH2 overexpression in NSCLC is demonstrated with new genetically engineered mouse models of lung adenocarcinoma, and a potent open-source EZh2 inhibitor, JQEZ5, is developed that promotes regression of EzH2-driven tumors in vivo, revealing a potential role for anti-EZH1 therapy in lung cancer and providing the rationale for epigenetic therapy in a subset of lung cancer.
Journal ArticleDOI
Chromatin immunoprecipitation from fixed clinical tissues reveals tumor-specific enhancer profiles
Paloma Cejas,Lewyn Li,Nicholas K. O’Neill,Melissa Duarte,Prakash Rao,Michaela Bowden,Chensheng W. Zhou,Marta Mendiola,Emilio Burgos,Jaime Feliu,Juan Moreno-Rubio,Héctor Guadalajara,Victor Moreno,Damián García-Olmo,Joaquim Bellmunt,Stephanie A. Mullane,Michelle S. Hirsch,Christopher Sweeney,Andrea L. Richardson,X. Shirley Liu,Myles Brown,Ramesh A. Shivdasani,Henry W. Long +22 more
TL;DR: Fixed-tissue chromatin immunoprecipitation sequencing (FiT-seq) is described, a method that enables reliable extraction of soluble chromatin from formalin-fixed paraffin-embedded (FFPE) tissue samples for accurate detection of histone marks.